Early Diagnosis of CVD «PHOCNOSIS»
European Commission, Horizon 2020 Project
Cardiovascular Disease (CVD) is the leading cause of death in the European Union accounting for 1.9 million deaths, i.e. 40% of all deaths in the EU each year. Despite costs of almost €196 billion per year, CVD can be successfully treated and managed – if detected early. The goal of the «PHOCNOSIS» project is the development and pre-clinical validation of a nanotechnology-based, handheld point-of-care testing (POCT) and analysis procedure and device, for fast and early diagnosis of cardiovascular diseases (CVD).
The «PHOCNOSIS» consortium |
|
Our Contribution
Art of Technology is responsible for the design and development of the electronics, mechanics, software and system integration of the POCT device. Using new nano-photonic sensing techniques developed by the Polytechnic University of Valencia, it should be possible using only a few drops of the patient’s blood, to measure and evaluate the concentration levels of different markers for cardiovascular disease in less than 10 minutes.